• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

基于肾脏功能标志物的结构方程模型(SEM)与纵向 CVD 风险评估。

Structural equation modeling (SEM) of kidney function markers and longitudinal CVD risk assessment.

机构信息

Institute for Biomedicine (Affiliated to the University of Lübeck), Eurac Research, Bolzano, Bozen, Italy.

Department of Preventive Medical Science, Fujita Health University School of Medical Sciences, Toyoake, Japan.

出版信息

PLoS One. 2023 Apr 20;18(4):e0280600. doi: 10.1371/journal.pone.0280600. eCollection 2023.

DOI:10.1371/journal.pone.0280600
PMID:37079513
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10118200/
Abstract

Lower kidney function is known to enhance cardiovascular disease (CVD) risk. It is unclear which estimated glomerular filtration rate (eGFR) equation best predict an increased CVD risk and if prediction can be improved by integration of multiple kidney function markers. We performed structural equation modeling (SEM) of kidney markers and compared the performance of the resulting pooled indexes with established eGFR equations to predict CVD risk in a 10-year longitudinal population-based design. We split the study sample into a set of participants with only baseline data (n = 647; model-building set) and a set with longitudinal data (n = 670; longitudinal set). In the model-building set, we fitted five SEM models based on serum creatinine or creatinine-based eGFR (eGFRcre), cystatin C or cystatin-based eGFR (eGFRcys), uric acid (UA), and blood urea nitrogen (BUN). In the longitudinal set, 10-year incident CVD risk was defined as a Framingham risk score (FRS)>5% and a pooled cohort equation (PCE)>5%. Predictive performances of the different kidney function indexes were compared using the C-statistic and the DeLong test. In the longitudinal set, a SEM-based estimate of latent kidney function based on eGFRcre, eGFRcys, UA, and BUN showed better prediction performance for both FRS>5% (C-statistic: 0.70; 95% CI: 0.65-0.74) and PCE>5% (C-statistic: 0.75; 95%CI: 0.71-0.79) than other SEM models and different eGFR formulas (DeLong test p-values<3.21×10-6 for FRS>5% and <1.49×10-9 for PCE>5%, respectively). However, the new derived marker could not outperform eGFRcys (DeLong test p-values = 0.88 for FRS>5% and 0.20 for PCE>5%, respectively). SEM is a promising approach to identify latent kidney function signatures. However, for incident CVD risk prediction, eGFRcys could still be preferrable given its simpler derivation.

摘要

已知肾功能降低会增加心血管疾病(CVD)风险。目前尚不清楚哪种估算肾小球滤过率(eGFR)方程最能预测 CVD 风险增加,以及通过整合多个肾功能标志物是否可以改善预测。我们采用结构方程模型(SEM)对肾脏标志物进行分析,并将由此产生的综合指标的性能与已建立的 eGFR 方程进行比较,以在 10 年的基于人群的纵向设计中预测 CVD 风险。我们将研究样本分为一组仅具有基线数据的参与者(n=647;模型构建集)和一组具有纵向数据的参与者(n=670;纵向集)。在模型构建集中,我们基于血清肌酐或基于肌酐的 eGFR(eGFRcre)、胱抑素 C 或基于胱抑素的 eGFR(eGFRcys)、尿酸(UA)和血尿素氮(BUN)拟合了五个 SEM 模型。在纵向集中,10 年的 CVD 事件风险定义为 Framingham 风险评分(FRS)>5%和综合队列方程(PCE)>5%。使用 C 统计量和 DeLong 检验比较不同肾脏功能指标的预测性能。在纵向集中,基于 eGFRcre、eGFRcys、UA 和 BUN 的 SEM 估计的潜在肾脏功能对于 FRS>5%(C 统计量:0.70;95%CI:0.65-0.74)和 PCE>5%(C 统计量:0.75;95%CI:0.71-0.79)的预测性能均优于其他 SEM 模型和不同的 eGFR 公式(DeLong 检验 p 值<3.21×10-6 用于 FRS>5%,<1.49×10-9 用于 PCE>5%)。然而,新的推导标志物并不能优于 eGFRcys(DeLong 检验 p 值分别为 0.88 用于 FRS>5%和 0.20 用于 PCE>5%)。SEM 是一种很有前途的识别潜在肾脏功能特征的方法。然而,对于 CVD 事件风险预测,由于 eGFRcys 的推导更为简单,因此可能仍是首选。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e7a0/10118200/ef1b01b62d62/pone.0280600.g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e7a0/10118200/d255eac5c0f2/pone.0280600.g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e7a0/10118200/9b50cdae2a52/pone.0280600.g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e7a0/10118200/6cf18890a3e7/pone.0280600.g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e7a0/10118200/d61c8fadbdba/pone.0280600.g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e7a0/10118200/ef1b01b62d62/pone.0280600.g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e7a0/10118200/d255eac5c0f2/pone.0280600.g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e7a0/10118200/9b50cdae2a52/pone.0280600.g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e7a0/10118200/6cf18890a3e7/pone.0280600.g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e7a0/10118200/d61c8fadbdba/pone.0280600.g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e7a0/10118200/ef1b01b62d62/pone.0280600.g005.jpg

相似文献

1
Structural equation modeling (SEM) of kidney function markers and longitudinal CVD risk assessment.基于肾脏功能标志物的结构方程模型(SEM)与纵向 CVD 风险评估。
PLoS One. 2023 Apr 20;18(4):e0280600. doi: 10.1371/journal.pone.0280600. eCollection 2023.
2
Estimated Glomerular Filtration Rate (eGFR) based on cystatin C was associated with increased risk of hip and proximal humerus fractures in women and decreased risk of hip fracture in men, whereas eGFR based on creatinine was not associated with fracture risk in both sexes: The Tromsø Study.基于胱抑素 C 的估算肾小球滤过率 (eGFR) 与女性髋部和近端肱骨骨折风险增加相关,与男性髋部骨折风险降低相关,而基于肌酐的 eGFR 与两性的骨折风险均无相关性:特罗姆瑟研究。
Bone. 2021 Jul;148:115960. doi: 10.1016/j.bone.2021.115960. Epub 2021 Apr 14.
3
Impact of Kidney Function on Cardiovascular Risk and Mortality: A Comparison of South Asian and European Cohorts.肾功能对心血管风险和死亡率的影响:南亚和欧洲队列的比较。
Am J Nephrol. 2019;50(6):425-433. doi: 10.1159/000503873. Epub 2019 Oct 30.
4
Integrating multiple kidney function markers to predict all-cause and cardiovascular disease mortality: prospective analysis of 366 758 UK Biobank participants.整合多种肾功能标志物以预测全因死亡率和心血管疾病死亡率:对366758名英国生物银行参与者的前瞻性分析。
Clin Kidney J. 2024 Jul 5;17(8):sfae207. doi: 10.1093/ckj/sfae207. eCollection 2024 Aug.
5
Kidney Function as Risk Factor and Predictor of Cardiovascular Outcomes and Mortality Among Older Adults.老年人肾功能作为心血管结局和死亡率的危险因素和预测因素。
Am J Kidney Dis. 2021 Mar;77(3):386-396.e1. doi: 10.1053/j.ajkd.2020.09.015. Epub 2020 Nov 14.
6
Comparison of cystatin C- and creatinine-based estimated glomerular filtration rate to predict coronary heart disease risk in Japanese patients with obesity and diabetes.基于胱抑素C和肌酐的估算肾小球滤过率用于预测日本肥胖和糖尿病患者冠心病风险的比较
Endocr J. 2015;62(2):201-7. doi: 10.1507/endocrj.EJ14-0352. Epub 2014 Nov 14.
7
Residual Associations of Inflammatory Markers with eGFR after Accounting for Measured GFR in a Community-Based Cohort without CKD.在一个无慢性肾脏病的社区队列中,在考虑实测肾小球滤过率(GFR)后炎症标志物与估算肾小球滤过率(eGFR)的残余关联。
Clin J Am Soc Nephrol. 2016 Feb 5;11(2):280-6. doi: 10.2215/CJN.07360715. Epub 2015 Dec 14.
8
How to estimate kidney function in kidney transplant recipients with mild to moderate kidney impairment: comparison of estimated glomerular filtration (eGFR) values between creatinine-based GFR equations and cystatin C-based GFR equations for Japanese population.如何评估轻至中度肾功能损害的肾移植受者的肾功能:基于肌酐的肾小球滤过率(GFR)方程与基于胱抑素C的GFR方程在日本人群中的估算肾小球滤过率(eGFR)值比较。
Clin Exp Nephrol. 2014 Feb;18(1):130-4. doi: 10.1007/s10157-013-0811-y. Epub 2013 May 15.
9
Creatinine versus cystatin C for renal function-based mortality prediction in an elderly cohort: The Northern Manhattan Study.基于肌酐和胱抑素 C 的肾功能对老年队列人群死亡率的预测:北方曼哈顿研究。
PLoS One. 2020 Jan 15;15(1):e0226509. doi: 10.1371/journal.pone.0226509. eCollection 2020.
10
Glomerular filtration rate estimation in patients with type 2 diabetes: creatinine- or cystatin C-based equations?2 型糖尿病患者肾小球滤过率的估计:基于肌酐或胱抑素 C 的方程?
Diabetologia. 2011 Dec;54(12):2987-94. doi: 10.1007/s00125-011-2307-1. Epub 2011 Sep 23.

引用本文的文献

1
Cohort Profile: the Cooperative Health Research in South Tyrol study.队列简介:南蒂罗尔合作健康研究
Int J Epidemiol. 2025 Apr 12;54(3). doi: 10.1093/ije/dyaf064.
2
Association Between Blood Urea Nitrogen/Albumin and the Incidence as Well as Progression of Type 2 Diabetes.血尿素氮与白蛋白的比值和2型糖尿病的发病率及病情进展之间的关联
Nutrients. 2024 Dec 30;17(1):113. doi: 10.3390/nu17010113.
3
Relationships among Dioxin-like Mitochondria Inhibitor Substances (MIS)-Mediated Mitochondria Dysfunction, Obesity, and Lung Function in a Korean Cohort.

本文引用的文献

1
Comparison of glomerular filtration rate estimating formulas among Japanese adults without kidney disease.日本无肾脏疾病成年人肾小球滤过率估算公式的比较。
Clin Biochem. 2023 Jan;111:54-59. doi: 10.1016/j.clinbiochem.2022.10.011. Epub 2022 Nov 2.
2
New Creatinine- and Cystatin C-Based Equations to Estimate GFR without Race.新型基于肌酐和胱抑素 C 的估算肾小球滤过率方程,无需考虑种族因素。
N Engl J Med. 2021 Nov 4;385(19):1737-1749. doi: 10.1056/NEJMoa2102953. Epub 2021 Sep 23.
3
Ten things to know about ten cardiovascular disease risk factors.
韩国队列中类二噁英线粒体抑制剂物质(MIS)介导的线粒体功能障碍、肥胖与肺功能之间的关系。
Toxics. 2024 Oct 11;12(10):735. doi: 10.3390/toxics12100735.
4
Integrating multiple kidney function markers to predict all-cause and cardiovascular disease mortality: prospective analysis of 366 758 UK Biobank participants.整合多种肾功能标志物以预测全因死亡率和心血管疾病死亡率:对366758名英国生物银行参与者的前瞻性分析。
Clin Kidney J. 2024 Jul 5;17(8):sfae207. doi: 10.1093/ckj/sfae207. eCollection 2024 Aug.
关于十种心血管疾病风险因素需要了解的十件事。
Am J Prev Cardiol. 2021 Jan 23;5:100149. doi: 10.1016/j.ajpc.2021.100149. eCollection 2021 Mar.
4
Addition of cystatin C predicts cardiovascular death better than creatinine in intensive care.胱抑素 C 优于肌酐在重症监护中预测心血管死亡。
Heart. 2022 Feb;108(4):279-284. doi: 10.1136/heartjnl-2020-318860. Epub 2021 Apr 1.
5
A single number for advocacy and communication-worldwide more than 850 million individuals have kidney diseases.一个用于宣传和沟通的数字——全球超过8.5亿人患有肾脏疾病。
Kidney Int. 2019 Nov;96(5):1048-1050. doi: 10.1016/j.kint.2019.07.012. Epub 2019 Sep 30.
6
Distinct Dimensions of Kidney Health and Risk of Cardiovascular Disease, Heart Failure, and Mortality.肾脏健康与心血管疾病、心力衰竭和死亡风险的不同维度。
Hypertension. 2019 Oct;74(4):872-879. doi: 10.1161/HYPERTENSIONAHA.119.13339. Epub 2019 Aug 5.
7
Effects of smoking status, history and intensity on heart rate variability in the general population: The CHRIS study.吸烟状况、吸烟史和吸烟强度对普通人群心率变异性的影响:CHRIS 研究。
PLoS One. 2019 Apr 9;14(4):e0215053. doi: 10.1371/journal.pone.0215053. eCollection 2019.
8
Understanding the Model Size Effect on SEM Fit Indices.理解模型大小对结构方程模型拟合指数的影响。
Educ Psychol Meas. 2019 Apr;79(2):310-334. doi: 10.1177/0013164418783530. Epub 2018 Jun 29.
9
2019 ACC/AHA Guideline on the Primary Prevention of Cardiovascular Disease: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines.2019美国心脏病学会/美国心脏协会心血管疾病一级预防指南:美国心脏病学会/美国心脏协会临床实践指南工作组报告
Circulation. 2019 Sep 10;140(11):e596-e646. doi: 10.1161/CIR.0000000000000678. Epub 2019 Mar 17.
10
Forecasting life expectancy, years of life lost, and all-cause and cause-specific mortality for 250 causes of death: reference and alternative scenarios for 2016-40 for 195 countries and territories.预测 250 种死因的预期寿命、损失的生命年数以及全因和特定死因死亡率:2016-2040 年 195 个国家和地区的参考和替代情景。
Lancet. 2018 Nov 10;392(10159):2052-2090. doi: 10.1016/S0140-6736(18)31694-5. Epub 2018 Oct 16.